244 related articles for article (PubMed ID: 30368639)
1. Isolated DLco/VA reduction in systemic sclerosis patients: a new patient subset?
Corzo P; Pros A; Martinez-Llorens J; Molina L; Ling SF; Balcells E
Clin Rheumatol; 2018 Dec; 37(12):3365-3371. PubMed ID: 30368639
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline.
Colaci M; Giuggioli D; Sebastiani M; Manfredi A; Lumetti F; Luppi F; Cerri S; Ferri C
Reumatismo; 2015 Dec; 67(4):149-55. PubMed ID: 27215180
[TBL] [Abstract][Full Text] [Related]
3. Isolated diffusing capacity reduction in systemic sclerosis.
Steen VD; Graham G; Conte C; Owens G; Medsger TA
Arthritis Rheum; 1992 Jul; 35(7):765-70. PubMed ID: 1622414
[TBL] [Abstract][Full Text] [Related]
4. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.
Guarnieri G; Zanatta E; Mason P; Scarpa MC; Pigatto E; Maestrelli P; Cozzi F
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S80-6. PubMed ID: 25897784
[TBL] [Abstract][Full Text] [Related]
5. Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease.
Le Gouellec N; Duhamel A; Perez T; Hachulla AL; Sobanski V; Faivre JB; Morell-Dubois S; Lambert M; Hatron PY; Hachulla E; Béhal H; Matran R; Launay D; Remy-Jardin M
PLoS One; 2017; 12(8):e0181692. PubMed ID: 28763468
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different measures of diffusing capacity for carbon monoxide (DLCO) in systemic sclerosis.
Hudson M; Assayag D; Caron M; Fox BD; Hirsch A; Steele R; Gaudreau-Taillefer R; Tatibouet S; ; Rudski L; Baron M
Clin Rheumatol; 2013 Oct; 32(10):1467-74. PubMed ID: 23733274
[TBL] [Abstract][Full Text] [Related]
7. Relevance of partitioning DLCO to detect pulmonary hypertension in systemic sclerosis.
Sivova N; Launay D; Wémeau-Stervinou L; De Groote P; Remy-Jardin M; Denis G; Lambert M; Lamblin N; Morell-Dubois S; Fertin M; Lefevre G; Sobanski V; Le Rouzic O; Hatron PY; Wallaert B; Hachulla E; Perez T
PLoS One; 2013; 8(10):e78001. PubMed ID: 24205063
[TBL] [Abstract][Full Text] [Related]
8. Increase of pulmonary diffusing capacity in systemic sclerosis.
Dujić Z; Eterović D; Tocilj J; Andjelinović D
Br J Rheumatol; 1994 May; 33(5):437-41. PubMed ID: 8173847
[TBL] [Abstract][Full Text] [Related]
9. A study on pulmonary complications of systemic sclerosis in eastern India.
Ghosh A; Banerjee A; Biswas AK
Indian J Chest Dis Allied Sci; 2014; 56(4):231-5. PubMed ID: 25962196
[TBL] [Abstract][Full Text] [Related]
10. Reduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosis.
Ninagawa K; Kato M; Nakamura H; Abe N; Kono M; Fujieda Y; Oku K; Yasuda S; Ohira H; Tsujino I; Atsumi T
Rheumatol Int; 2019 Nov; 39(11):1883-1887. PubMed ID: 31280357
[TBL] [Abstract][Full Text] [Related]
11. [The clinical characteristics of systemic sclerosis-related pulmonary arterial hypertension].
Wang H; Tian Z; Liu Y; Li M; Wang Q; Zeng X; Fang Q
Zhonghua Nei Ke Za Zhi; 2014 May; 53(5):390-3. PubMed ID: 25146407
[TBL] [Abstract][Full Text] [Related]
12. Can we predict the severity of pulmonary hypertension in patients with scleroderma?
Acosta Colmán MI; Avila Pedretti G; Acosta ME; Simeón Aznar CP; Fonollosa Plá V; Villardel Torrés M
Reumatol Clin; 2012; 8(5):259-62. PubMed ID: 22658662
[TBL] [Abstract][Full Text] [Related]
13. Lysyl oxidase-a possible role in systemic sclerosis-associated pulmonary hypertension: a multicentre study.
Vadasz Z; Balbir Gurman A; Meroni P; Farge D; Levi Y; Ingegnoli F; Braun-Moscovici Y; Rosner I; Slobodin G; Rozenbaum M; Jiries N; Kaly L; Boulman N; Zilber K; Ginsberg S; Awisat A; Goldberg Y; Lurie M; Ghigna MR; Guignabert C; Humbert M; Rimar D
Rheumatology (Oxford); 2019 Sep; 58(9):1547-1555. PubMed ID: 30770717
[TBL] [Abstract][Full Text] [Related]
14. [Lung involvement in systemic sclerosis].
Quadrelli S; Ciallella L; Catalán Pellet AC; Molinari L; Salvado A; Auad C; Spina JC
Medicina (B Aires); 2007; 67(5):429-35. PubMed ID: 18051224
[TBL] [Abstract][Full Text] [Related]
15. Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.
Goh NS; Hoyles RK; Denton CP; Hansell DM; Renzoni EA; Maher TM; Nicholson AG; Wells AU
Arthritis Rheumatol; 2017 Aug; 69(8):1670-1678. PubMed ID: 28426895
[TBL] [Abstract][Full Text] [Related]
16. Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality.
Champtiaux N; Cottin V; Chassagnon G; Chaigne B; Valeyre D; Nunes H; Hachulla E; Launay D; Crestani B; Cazalets C; Jego P; Bussone G; Bérezné A; Guillevin L; Revel MP; Cordier JF; Mouthon L;
Semin Arthritis Rheum; 2019 Aug; 49(1):98-104. PubMed ID: 30409416
[TBL] [Abstract][Full Text] [Related]
17. [Single-breath and rebreathing methods for measurement of pulmonary diffusing function: a comparative study].
Liu QX; Zheng JP; Xie YQ; Guan WJ; Jiang CY; An JY; Yu XX; Liu WT; Gao Y
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):510-5. PubMed ID: 24262087
[TBL] [Abstract][Full Text] [Related]
18. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
[TBL] [Abstract][Full Text] [Related]
19. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement.
Steen V; Medsger TA
Arthritis Rheum; 2003 Feb; 48(2):516-22. PubMed ID: 12571862
[TBL] [Abstract][Full Text] [Related]
20. Antinuclear antibody-negative systemic sclerosis.
Salazar GA; Assassi S; Wigley F; Hummers L; Varga J; Hinchcliff M; Khanna D; Schiopu E; Phillips K; Furst DE; Steen V; Baron M; Hudson M; Taillefer SS; Pope J; Jones N; Docherty P; Khalidi NA; Robinson D; Simms RW; Silver RM; Frech TM; Fessler BJ; Molitor JA; Fritzler MJ; Segal BM; Al-Kassab F; Perry M; Yang J; Zamanian S; Reveille JD; Arnett FC; Pedroza C; Mayes MD
Semin Arthritis Rheum; 2015 Jun; 44(6):680-6. PubMed ID: 25578738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
